Ginpreet Kaur

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Cognitive Impairment

Top Venues

Pharmaceutical patent analyst

Fish physiology and biochemistry

Journal of food biochemistry

Naunyn-Schmiedeberg's archives of pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Vivek S Kumawat, Ginpreet Kaur
Cannabinoid receptor 2 (CB 2 ) agonists and L-arginine ameliorate diabetic nephropathy in rats by suppressing inflammation and fibrosis through NF-κβ pathway. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Rajiv Kumar, Bhupender S Chhikara, Simge Er Zeybekler, Dhruv Sanjay Gupta, Ginpreet Kaur, Mitrabasu Chhillar, Anil K Aggarwal, Abbas Rahdar
Nanotoxicity of multifunctional stoichiometric cobalt oxide nanoparticles (SCoONPs) with repercussions toward apoptosis, necrosis, and cancer necrosis factor (TNF-α) at nano-biointerfaces. Toxicology research 12 (5) (2023)
Baban S Thawkar, Ginpreet Kaur
Betanin mitigates scopolamine-induced cognitive impairment by restoring cholinergic function, boosting brain antioxidative status, and increasing BDNF level in the zebrafish model. Fish physiology and biochemistry (2023)
Shubhangi Gupta, Harpal S Buttar, Ginpreet Kaur, Hardeep Singh Tuli
Baicalein: promising therapeutic applications with special reference to published patents. Pharmaceutical patent analyst 11 (1) (2022)
Vivek S Kumawat, Ginpreet Kaur
Insulinotropic and antidiabetic effects of β-caryophyllene with l-arginine in type 2 diabetic rats. Journal of food biochemistry 44 (4) (2020)